Long-acting injectable buprenorphine is also known by the brand names Buvidal or Sublocade.
Academic rigour, journalistic flair
Articles on Opioid addiction
Displaying 1 - 20 of 29 articles
Unlike opioid drugs like morphine and fentanyl that travel throughout the body, the opioids your body produces are released in small quantities to specific locations.
The six young men took very different routes to recovery. Their experiences hold important lessons for managing opioid addiction.
Non-opioid directives allow patients to refuse opioids in all health care settings. For surgical procedures that require anesthesia, however, this may do more harm than good.
Game making is an art form that many aren’t intimately familiar with. Unlike other creative practices, game makers must create the rules and laws that govern and shape player behaviours.
Firefighters are hailed as heroes and pillars of strength, bravery and courage. But the daily stressors and traumas of their jobs take a heavy emotional toll that largely goes unnoticed by the public.
COVID-19 plagues an overtaxed opioid addiction treatment system.
Aggressive marketing of prescription opioids by pharmaceutical companies provided doctors with scant information about potential harmful effects.
Urgently needed treatment for opioid use disorder is often denied to incarcerated people, feeding the crisis in prisons and jails.
There’s widespread attention on the dangers of opioid addiction, but use of damaging crystal meth continues in the U.S., with police seizures rising.
Treatments for opioid dependence, such as methadone and buprenorphine, are effective. But some people who stand to benefit are missing out.
About 1 in 4 people prescribed an opioid for pain end up abusing it. New methods to reduce the need for opioids after surgery have been shown to work – and thus minimize the need for such drugs.
Considered in historical context, Purdue’s plan to peddle opioid addiction medicines to vulnerable people is not so surprising. Gilded-Age pharmaceutical companies used similar strategies.
The toll of the opioid epidemic is often derived from toxicology reports. These rely on drug tests. A medical historian explains these tests and how they fall short of capturing why people are dying.
The opioid crisis in the US has quadrupled the number of babies born addicted to drugs.
A bill to deal with the opioid crisis recently came out of a Senate committee. While some of its recommendations are good, some key points are missing.
Opioid addiction is a serious public health problem, killing more than 42,000 people a year and ruining families. But alcohol is still the deadliest drug in the US. An addiction expert tells why.
As the nation grapples with its opioid addiction epidemic, an understanding of how the drugs affect people is important. The powerful class of drugs actually can change the brain.
The claim there is no evidence painkillers combined with lower doses of codeine are more effective in treating pain, is misleading. As are others in this debate.
How can we fight the opioid epidemic? Redesign the drugs, rethink how we assess patients and mandate prescription monitoring.
Top contributors
-
Associate Professor of Medicine, University of Florida
-
Chancellor's Professor of Medicine, Liberal Arts, and Philanthropy, Indiana University
-
Assistant Professor, University of Colorado Boulder
-
Dean, Perimeter College & Professor, Social Work, Georgia State University
-
Associate Dean and Chief Academic Officer for Nursing and Director, Project Healthy Grandparents, Byrdine F. Lewis College of Nursing and Health Professions, Georgia State University
-
Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Professor of Sociology, Suffolk University
-
Division Chief, Pain Medicine, Vanderbilt University
-
Professor of Public Health, Georgia State University
-
Associate Professor, Psychiatry, University of Florida
-
Assistant Professor, Psychiatry, University of Florida
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor of Public Health, Texas A&M University
-
Adjunct Fellow, UNSW Sydney
